HAEMATOLOGY AUDIT TEMPLATE

First Page		Document Content
Date: 2015-09-20 08:20:56 Myelofibrosis Janus kinase inhibitor Splenomegaly Myeloproliferative neoplasm Ruxolitinib Medical diagnosis Polycythemia vera		HAEMATOLOGY AUDIT TEMPLATE Add to Reading List Source URL: www.bcshguidelines.com Download Document from Source Website File Size: 2,47 MB Share Document on Facebook

	HAEMATOLOGY AUDIT TEMPLATE DocID: 1pL02 - View Document
	Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016 DocID: 1pn6V - View Document
	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca DocID: 19fx5 - View Document
	Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b DocID: 11mkK - View Document
	ruxolitinib (as phosphate), 5mg, 15mg, & 20mg tablets (Jakavi®) SMC No[removed]Novartis Pharmaceuticals UK Ltd. 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above produc DocID: YQ1v - View Document